Toshiaki Usui Selected Research

Duane Retraction Syndrome (Duane Syndrome)

1/2020	Phenotypic analysis of mice carrying human-type MAFB p.Leu239Pro mutation.
1/2018	A mutation in transcription factor MAFB causes Focal Segmental Glomerulosclerosis with Duane Retraction Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshiaki Usui Research Topics

Disease

4	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2020 - 01/2018
2	Duane Retraction Syndrome (Duane Syndrome) 01/2020 - 01/2018
2	Proteinuria 01/2020 - 01/2020
1	Kidney Diseases (Kidney Disease) 03/2022
1	Renal Insufficiency (Renal Failure) 01/2020
1	Chronic Renal Insufficiency 01/2018
1	Hypocalcemia 01/2018
1	Secondary Hyperparathyroidism 01/2018
1	Glomerulonephritis 09/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2017
1	Autosomal Dominant Polycystic Kidney (ADPKD) 05/2016
1	Pain (Aches) 05/2016

Drug/Important Bio-Agent (IBA)

3	MafB Transcription FactorIBA 01/2020 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	SteroidsIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Adenine FDA LinkGeneric 01/2018
1	Parathyroid Hormone (Parathormone)IBA 01/2018
1	Cyclin D2IBA 01/2018
1	antiglomerular basement membrane antibodyIBA 09/2017
1	Tolvaptan FDA Link 05/2016

Therapy/Procedure

1	Plasmapheresis 09/2017
1	Aftercare (After-Treatment) 05/2016